Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study

  title={Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study},
  author={Jon-Kar Zubieta and Mark K. Greenwald and Umberto Lombardi and James H. Woods and Michael R. Kilbourn and Douglas M. Jewett and Robert A. Koeppe and Charles Roberts Schuster and Chris Ellyn Johanson},

Figures and Tables from this paper

Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers
It is suggested that high-dose BUP maintenance produces near-maximal μOR occupation, μOR availability correlates well with plasma levels, and BUP-related opioid symptoms and antagonist blockade exhibit concentration–effect relationships.
Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans
High-dose buprenorphine attenuated opioid drug-seeking behavior, heroin craving self-reports and increased sensitivity to alternative reinforcement as well as influencing choice of, and operant responding for, hydromorphone versus money.
Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice
The results of the investigation on the roles of μ-, δ-, and κ-opioid receptors in antinociceptive responses and place preferences induced by buprenorphine support the ideas that μ-opIOid receptors mediate most of analgesic properties of bupenorphine, but thatμ- and δ- and/or λ-opiosid receptors are each involved in the rewarding effects of this drug.
Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo
This strategy could be further combined with pharmacodynamic exploration or pharmacological MRI to investigate the neuropharmacokinetics and neuroreceptor correlate, at least at µ-OR, of the acute effects of buprenorphine in humans.
The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
It is reported for the first time that intrathecal buprenorphine is approximately 17 times more effective than hydromorphone in inhibiting thermal pain, and bupenorphine produces its antinociceptive effect by acting as an agonist at both mu- and kappa-spinal opioid receptors.
Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.
The pharmacokinetic and pharmacodynamic properties of buprenorphine allow it to be a feasible option for substitution therapy in the treatment of opioid dependence.


Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
The results of this study confirm previous reports of buprenorphine blockade of opioid agonist effects in humans and extent those findings by demonstrating both a bup Renorphine dose-effect function and a dissociation between the potency of bu prenorphin's opioid blockade for self-report vs. physiological measures.
Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance.
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.
Buprenorphine treatment of opioid dependence: A review.
The research suggests that inducting patients onto buprenorphine should lead to limited discomfort if appropriate procedures are followed, and that discontinuing bupRenorphine treatment appears to result in a mild-to-moderate opioid withdrawal syndrome that is less severe than that observed with full-efficacy agonists.
Buprenorphine suppresses heroin use by heroin addicts.
Buprenorphine should be a safe and effective new pharmacotherapy for heroin dependence and indicated that it was preferable to methadone or naltrexone.
Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
It is indicated that buprenorphine is a useful tool to study brain opioid receptor adaptation in vivo and agonist-induced opioid receptor down-regulation is difficult to elicit in adult mammalian brain.
Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.
Modulation of hypothalamic alpha 2-adrenoceptor density during morphine withdrawal is a relevant physiological mechanism by which the opiate abstinence syndrome is counteracted.
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
Buprenorphine: duration of blockade of effects of intramuscular hydromorphone.